Anti-recurrent Immunocorrection in Gynecology Andrology and Proctology
Vasyl Beniuk,
Vadym Goncharenko,
Andrii Kurchenko,
Oleksii Tatskyy,
Sergii Konovalenko,
Svitlana Vintoniuk,
Sergii Melnikov,
Kamil Nurimanov,
Sergii Podpriatov
Issue:
Volume 8, Issue 1, March 2020
Pages:
1-8
Received:
7 February 2020
Accepted:
21 February 2020
Published:
2 March 2020
Abstract: The article provides evidence of clinical experience with the use of Arecur® for the treatment of endocervicitis and dysplasia of the cervix, endometrioma, chronic bacterial prostatitis, and for postoperative rehabilitation in patients after removal of hemorrhoids. Arecur® contains exogenous peptides of natural origin – anti-infective proteins of the group of defensins and RJP-1 and has antibacterial, antiviral, anti-inflammatory and antitumor activity. In the study groups, in which Arecur® was assigned to the patients, were reported significantly better clinical efficacy results. The ability of exogenous peptides to mobilize T-lymphocytes to identify and destroy infected and atypical cells determines the elimination of human papilloma virus and creates the conditions for reducing the risk of malignant cell transformation of cervical canal. Arecur®, by enhancing the immune supervision of ectopic endometrial cells, promotes regression of clinical symptoms and prolongation of inter-relapsing intervals in patients with endometriosis. In chronic bacterial prostatitis Arecur® increases the efficiency of etiotropic and symptomatic therapy. After surgical removal of hemorrhoid lesions, Arecur® provides more positive dynamics of rehabilitation, improves patients' quality of life and prevents complications. The obtained results allow us to reasonably recommend Arecur® as a medicine for anti-recurrent immunocorrection in gynecology, andrology and proctology.
Abstract: The article provides evidence of clinical experience with the use of Arecur® for the treatment of endocervicitis and dysplasia of the cervix, endometrioma, chronic bacterial prostatitis, and for postoperative rehabilitation in patients after removal of hemorrhoids. Arecur® contains exogenous peptides of natural origin – anti-infective proteins of t...
Show More
The Usual Suspects' but Always Ignored: The Nutritional and Immune System's Status Affect the Infective Endocarditis Hospital Mortality
Ozlem Arican Ozluk,
Ayse Akdeniz,
Elif Guclu,
Burcu Tuncay,
Tahsin Bozat
Issue:
Volume 8, Issue 1, March 2020
Pages:
9-12
Received:
6 April 2020
Accepted:
5 May 2020
Published:
14 May 2020
Abstract: The therapy of Infective Endocarditis is a very long and difficult. There are many factors that affected the management of therapy. Among them, maybe the most ignored factor belongs to the patient's' immune-nutrition status. Even though this assessment is more complicated; in recent years, prognostic nutritional index (PNI) was an established that inflammation-based nutritional score and the lymphocyte to-CRP ratio (LCR) was accepted as a marker of immune-inflammation's marker. Our study is aimed to investigate the relationship between LCR and PNI values and in-hospital mortality. Our comprehensive tertiary cardiology hospital in Turkey was included in this observational study, 36 patients with definite infective endocarditis were enrolled. We calculated LCR and PNI index from blood samples results of first hospitalization day. P-value < 0.05 was considered as statistically significant. In hospital mortality occurred in 12 (33%). LCR index was significantly lower in hospital mortality group (p=0.04) PNI index was also lower in hospital mortality group but it was not significant. The nutritional and immune system's status of the patient at the beginning of the treatment determines the hospital mortality of the patient during challenging treatment. In this context, the assessment of the PNI index and lymphocyte to-CRP ratio could aid physicians in determining hospital mortality risk and could affect the management of infective endocarditis patients.
Abstract: The therapy of Infective Endocarditis is a very long and difficult. There are many factors that affected the management of therapy. Among them, maybe the most ignored factor belongs to the patient's' immune-nutrition status. Even though this assessment is more complicated; in recent years, prognostic nutritional index (PNI) was an established that ...
Show More
